At only two days old, Sophie was losing too much weight, and too quickly. Further genetic testing would show that Sophie has ...
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...
Further genetic testing would show that Sophie has one of a group of rare conditions called CODE (congenital diarrhea and enteropathies) that disrupts the function of cells in the intestine, causing ...
The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...
A key pressure-sensing protein involved in gut motility could be utilized for precision-targeted treatments for intestinal ...
In Singapore, scientists have been studying a particular subtype called Blastocystis ST7. This version of Blastocystis is ...
Diarrhea can range from a mild, temporary condition to a potentially life threatening one. Common causes include viruses, bacteria, and parasites. Diarrhea is characterized by loose or watery ...
US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...